Table 1.
Number (%) of new bacteriologically confirmed pulmonary tuberculosis cases tested and identified with rifampicin resistant TB, Cameroon 2017
| Region | PTB+ NC notified | Number (%) PTB+ NC sampled | Number (%) PTB+ NC with RR notified | 95% CI proportion PTB+ NC with RR |
|---|---|---|---|---|
| Littoral | 241 | 212 (88) | 2 (0.9) | 0–2.2 |
| NW | 159 | 103 (65) | 2 (1.9) | 0–4.6 |
| West | 71 | 71 (100) | 1 (1.4) | 0–4.1 |
| Est | 97 | 61 (63) | 0 | – |
| Ada | 95 | 83 (87) | 1 (1.2) | 0–3.6 |
| Nord | 141 | 120 (85) | 4 (3.3) | 0.1–6.5 |
| EN | 211 | 95 (45) | 2 (2.1)* | 0–5.0 |
| CE | 283 | 136 (48) | 2 (1.5) | 0–3.5 |
| Sud | 88 | 66 (75) | 0 | – |
| SW | 92 | 82 (89) | 2 (2.4) | 0–5.8 |
| Pays | 1478 | 1029 (70) | 16 (1.6) | 0.8–2.3 |
* Test result of patients not confirmed by a second Xpert exam